Understanding Ketamine's Dissociative Effects (KD Study)
RecruitingPhase 1
Understanding Ketamine's Dissociative Effects in Epilepsy (KD Study)
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Patient in Stanford Epilepsy Monitoring Unit * Age \>18 years old. Exclusion Criteria: * Lifetime psychotic or bipolar disorder * Inability to speak, read or understand English * Pregnant or nursing females * Prior adverse ketamine response
About the study
The purpose of this study is to understand how ketamine brings about dissociative symptoms.
What is being tested
- Ketamine (drug)
Sponsor: Stanford University · Participants: 20 · Started: Jul 26, 2021
Contact the study team
- Arjay Cordero · Phone: 650-580-9000
Official record on ClinicalTrials.gov — NCT04861051
Locations in the U.S.
| California | Stanford University School of Medicine, Palo Alto |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.